Results 161 to 170 of about 802,617 (317)
Diagnostic Ambiguity in BCR-ABL1-Positive MPAL in a Resource-Limited Setting: A Case Report. [PDF]
Poudel S +4 more
europepmc +1 more source
We developed Affinity Selection Thin‐Layer Chromatography (AS‐TLC) as a method for high‐throughput screening (HTS) of compound mixtures. Furthermore, we integrated activity assays with AS‐TLC and identified a YTH domain‐containing protein 1 (YTHDC1) inhibitor. Building on this hit, we applied copper(I)‐catalyzed azide–alkyne cycloaddition (CuAAC) click
Mingchen Wang +19 more
wiley +1 more source
Two ways to complex karyotype in MDS—the role of del(5q) and TP53
Sandra Huber +7 more
doaj +1 more source
Biohybrid M13 phage backpacks for active blood-brain barrier traversal and precision central nervous system leukemia treatment. [PDF]
Wu W +5 more
europepmc +1 more source
An m6A‐modified circRNA, circPSMB1, is identified as a tumor suppressor in chordoma. METTL3‐dependent m6A promotes circPSMB1 interaction with HNRNPA2B1, limiting c‐MYC expression and malignant progression. An injectable HMnO2‐based nanohydrogel enables local circPSMB1 delivery and tumor microenvironment‐responsive therapy, offering a promising strategy
Yingchuang Tang +7 more
wiley +1 more source
Diagnostic yield of cancer predisposition in a nationwide prospective childhood acute leukemia cohort. [PDF]
Taylan F +37 more
europepmc +1 more source
The injectable CeTA@GPP hydrogel is administered via intrauterine injection, forming a protective barrier. In the high ROS inflammatory microenvironment of injured endometrium, boronate ester cleavage triggers responsive CeTA release and local enrichment.
Peixian Cheng +8 more
wiley +1 more source

